President Donald Trump is criticizing high drug prices again, sending health-care stocks lower Monday. The president tweeted that “Pharma has a lot of lobbyists and campaign contributions coming into play to keep our country from negotiating better deals for the American people.”
President Donald Trump is criticizing high drug prices again, sending health-care stocks lower Monday. The iShares Nasdaq Biotech ETF erased its gains for the day after Trump's comments, which were released around 11:50 a.m. EDT.